Does metabolic syndrome influence the efficacy of mirabegron treatment in female patients with overactive bladder?
Crossref DOI link: https://doi.org/10.1007/s00192-022-05261-y
Published Online: 2022-06-14
Published Print: 2023-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kinjo, Manami https://orcid.org/0000-0002-4508-6173
Masuda, Kazuki
Nakamura, Yu
Taguchi, Satoru
Tambo, Mitsuhiro
Fukuhara, Hiroshi
Text and Data Mining valid from 2022-06-14
Version of Record valid from 2022-06-14
Article History
Received: 1 March 2022
Accepted: 23 May 2022
First Online: 14 June 2022
Declarations
:
: None